T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SFBS
1501
ServisFirst Bancshares
SFBS
$4.99B
| $3.57M | ﹤0.01% |
49,750
+2,719
| +6% | +$200K |
|
1502
Rush Street Interactive
RSI
$2.96B
| $3.56M | ﹤0.01% |
183,134
+115,074
| +169% | +$2.13M |
|
1503
SoundHound AI
SOUN
$3.27B
| $3.56M | ﹤0.01% |
356,880
-6,419,952
| -95% | -$92.4M |
|
1504
MSC Industrial Direct
MSM
$6.89B
| $3.53M | ﹤0.01% |
41,915
+3,227
| +8% | +$280K |
|
1505
Upstart Holdings
UPST
$2.96B
| $3.52M | ﹤0.01% |
80,379
-911,054
| -92% | -$41.9M |
|
1506
Bread Financial
BFH
$4.56B
| $3.49M | ﹤0.01% |
47,100
+644
| +1% | +$42.3K |
|
1507
Assured Guaranty
AGO
$3.36B
| $3.48M | ﹤0.01% |
38,677
+1,200
| +3% | +$103K |
|
1508
Terex
TEX
$7.79B
| $3.46M | ﹤0.01% |
64,899
+2,681
| +4% | +$135K |
|
1509
Transocean
RIG
$6.48B
| $3.45M | ﹤0.01% |
835,391
+126,275
| +18% | +$490K |
|
1510
Sphere Entertainment
SPHR
$6.08B
| $3.45M | ﹤0.01% |
36,263
+145
| +0.4% | +$11K |
|
1511
ICU Medical
ICUI
$4.56B
| $3.42M | ﹤0.01% |
23,991
+1,008
| +4% | +$135K |
|
1512
Snap
SNAP
$9.12B
| $3.42M | ﹤0.01% |
423,639
-9,200
| -2% | -$72.8K |
|
1513
Cal-Maine
CALM
$3.8B
| $3.42M | ﹤0.01% |
42,945
-217,422
| -84% | -$19.1M |
|
1514
Peabody Energy
BTU
$3.1B
| $3.41M | ﹤0.01% |
114,940
+5,991
| +5% | +$176K |
|
1515
Sonoco
SON
$5.74B
| $3.4M | ﹤0.01% |
77,963
+3,618
| +5% | +$150K |
|
1516
TeraWulf
WULF
$8.6B
| $3.4M | ﹤0.01% |
295,673
-3,758,214
| -93% | -$50.4M |
|
|
UCB
1517
United Community Banks
UCB
$4.43B
| $3.39M | ﹤0.01% |
108,580
+3,322
| +3% | +$103K |
|
1518
Tanger
SKT
$4.41B
| $3.39M | ﹤0.01% |
101,534
+3,007
| +3% | +$100K |
|
|
OMDA
1519
Omada Health Inc
OMDA
$1.46B
| $3.39M | ﹤0.01% |
+214,508
| New | +$4.35M |
|
1520
KB Home
KBH
$3.44B
| $3.38M | ﹤0.01% |
59,850
-8
| -0% | -$492 |
|
|
TGNA
1521
DELISTED
TEGNA Inc
TGNA
| $3.37M | ﹤0.01% |
173,734
+17,726
| +11% | +$350K |
|
1522
Entrada Therapeutics
TRDA
$285M
| $3.37M | ﹤0.01% |
327,423
-33,103
| -9% | -$279K |
|
1523
Enphase Energy
ENPH
$5.32B
| $3.37M | ﹤0.01% |
104,963
+2,266
| +2% | +$73.4K |
|
1524
National Health Investors
NHI
$3.6B
| $3.37M | ﹤0.01% |
44,055
+2,313
| +6% | +$177K |
|
1525
WesBanco
WSBC
$4.09B
| $3.36M | ﹤0.01% |
101,050
+2,413
| +2% | +$78K |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.